Sfoglia per Rivista
Relationship between cytogenetic anomalies and biomarkers in Binet stage A patients with Chronic Lymphocytic Leukemia at diagnosis : preliminary results of a prospective, multicenter O-CLL1 GISL study
2009 S. Fabris, G. Cutrona, M. Gentile, S. Matis, E.A. Pesce , F. Di Raimondo, C. Musolino, M. Gobbi, N. Di Renzo, F.R. Mauro, R. Cantaffa, M. Brugiatelli, F. Merli, S. Zupo, C. Mammi, L. Baldini, F. Angrilli, G. Quintana, U. Consoli, G. Bertoldero., E. Iannitto, P. Di Tonno, A. Fragasso, S. Molica, P. Musto, M.C. Cox, G. Festini, V. Callea, S. Sacchi, A. Cortelezzi, G. Lambertenghi Deliliers
Relationship between expression of TLRS and disease activity in B-CLL
2009 W. Barcellini, A. Zaninoni, F.G. Imperiali, G. Reda, A. Cortelezzi, A. Zanella
Relationship between GDF-15 (Growth differentiation factor 15) and iron overload in thalassemia intermedia patients
2010 L. Duca, I. Nava, G. Graziadei, C. Cesaretti, M.D. Cappellini
Relationships between plasma non-transferrin-bound iron and markers of iron overload, anaemia and ineffective erythropoiesis in non-transfusion-dependent thalassaemia syndromes
2011 J. Porter, M.D. Cappellini, A. Kattamis, V. Viprakasit, T. Lawniczek, J. Ros, W. Deng, A. Taher
Relative contribution of iron genes, dysmetabolism and hepatitis C virus (HCV) in the pathogenesis of altered iron regulation in HCV chronic hepatitis
2007 L. Valenti, E.A. Pulixi, P. Arosio, L. Cremonesi, G. Biasiotto, P. Dongiovanni, M. Maggioni, S. Fargion, A.L. Fracanzani
Relevance of chromosome 2P gain in early Binet stage A chronic lymphocytic leukemia
2012 S. Fabris, L. Mosca, G. Cutrona, L. Agnelli, M. Lionetti, S. Matis, M. Gentile, F. Maura, E.A. Pesce, A.G. Recchia, F. Di Raimondo, C. Musolino, M. Gobbi, N. Di Renzo, F.R. Mauro, R. Cantaffa, M. Brugiatelli, F. Merli, S. Zupo, C. Mammi, L. Baldini, F. Angrilli, G. Quintana, U. Consoli, G. Bertoldero, E. Iannitto, P. Di Tonno, A. Fragasso, S. Molica, P. Musto, M.C. Cox, G. Festini, V. Callea, S. Sacchi, G. Lambertenghi Deliliers, A. Cortelezzi, R. Foà, M. Federico, F. Morabito, M. Ferrarini, A. Neri
Renal function in patients with thalassemia intermedia
2010 A. Taher, K. Musallam, G. Al Helou, M.D. Cappellini, F. Ziyadeh
Repetitive DNA methylation in multiple myeloma
2008 S. Fabris, V. Bollati, D. Ronchetti, L. Mosca, M. Zappa, G. Lambertenghi Deliliers, P.A. Bertazzi, A. Baccarelli, A. Neri
Reply to: [Factor XI mutation and the origin of Ashkenazi Jews. Haematologica 2008; 93:e59]
2008 G. Zadra, R. Asselta, M.L. Tenchini, G. Castaman, U. Seligsohn, P.M. Mannucci, S. Duga
Report from the European myeloma network on interphase FISH in multiple myeloma and related disorders
2012 F.M. Ross, H. Avet Loiseau, G. Ameye, N.C. Gutiérrez, P. Liebisch, S. O'Connor, K. Dalva, S. Fabris, A.M. Testi, M. Jarosova, C. Hodkinson, A. Collin, G. Kerndrup, P. Kuglik, D. Ladon, P. Bernasconi, B. Maes, Z. Zemanova, K. Michalova, L. Michau, K. Neben, N..E.U. Hermansen, K. Rack, A. Rocci, R. Protheroe, L. Chiecchio, H.A. Poirel, P. Sonneveld, M. Nyegaard, H.E. Johnsen, E. Myeloma Network
Rescue FVIII replacement to secure haemostasis in a patient with haemophilia A and inhibitors on emicizumab prophylaxis undergoing hip replacement
2019 E. Santagostino, M.E. Mancuso, C. Novembrino, L.P. Solimeno, A. Tripodi, F. Peyvandi
Rescue of activated protein C-resistance phenotype by cis-acting factor V Gly2032Asp mutation
2004 R. Asselta, A. Bossone, L. Iannaccone, S. Duga, V. Brancaccio, M. Margaglione
Residual venous obstruction and D-dimer as risk factors for recurrence after anticoagulation withdrawal for a first idiopathic deep vein thrombosis in the prolong study
2008 B. Cosmi, C. Legnani, A. Tosetto, A. Tripodi, V. Pengo, E. Conti, L. Valdrè, G. Palareti
Resistance to antiplatelet agents : review of the literature and some methodological considerations.
2004 M. Cattaneo
Response-based chemoterapy and involved field radiation for intermediate stage hodgkin disease a GISL/NHLSG trial
2007 E. Iannitto, V. Minardi, P.G. Gobbi, S. Luminari, G. Calvaruso, C. Stelinato, L. Baldini, F. Merli, M. Petrini, L. Marcheselli, C. Mammi, S. Da Cantis, V. Abbadessa, M. Federico
Restriction enzyme study on highly repeated DNAs of human leukemic leukocytes
1982 G. Corneo, L. Ceccherini Nelli, D. Meazza, P. Tripputi, M. Bregni
Resveratrol accelerates erythroid maturation by activation of FoxO3 and ameliorates anemia in beta-thalassemic mice
2014 S. Sanatos Franco, L. De Falco, S. Ghaffari, C. Brugnara, D.A. Sinclair, A. Matte', A. Iolascon, N. Mohandas, M. Bertoldi, X. An, A. Siciliano, P. Rimmelé, M.D. Cappellini, S. Michan, E. Zoratti, J. Anne, L. De Franceschi
A retained transcriptomic profile characterizes CD138+ cells in the short time progression from smoldering to active multiple myeloma
2019 P. Storti, L. Agnelli, B. dalla Palma, K. Todoerti, V. Marchica, F. Accardi, G. Sammarelli, F. Deluca, D. Toscani, F. Costa, E. Vicario, G. Todaro, E. Martella, A. Neri, N. Giuliani
Retrospective analysis of salvage regimen for relapsed or refractory classical Hodgkin lymphoma
2011 D. Vincenti, A. Ferrario, N. Orofino, M. Goldaniga, F. Rossi, C. Annaloro, E. Tagliaferri, F. Onida, B. Olivero, L. Baldini
Risk factors for progression to blast phase in patients with Myelofibrosis treated with Ruxolitinib: an Italian study on 589 patients
2019 F. Palandri, M. Breccia, N. Polverelli, M. Tiribelli, G. Benevolo, A. Tieghi, G. Binotto, M. Bonifacio, B. Martino, A. Iurlo, E.M. Elli, E. Abruzzese, M. Bergamaschi, N. Sgherza, F. Cavazzini, M. Crugnola, C. Bosi, A. Isidori, G. Auteri, E. Sutto, R. Latagliata, D. Griguolo, K. Codeluppi, D. Cattaneo, M. Trawinska, D. Bartoletti, M. Krampera, G. Semenzato, R.M. Lemoli, A. Cuneo, F. Di Raimondo, M. Cavo, N. Vianelli, G.A. Palumbo
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile